CBD CBG crystal resistant distillate for advanced broad spectrum formulation.

CBD CBG Crystal Resistant Distillate from Cilo Cybin's GMP cannabinoid API portfolio: Near 1:1 CBD and CBG with up to 80% total cannabinoids, low-viscosity amber.

This page provides supporting information about Cilo Cybin's company platform, products, services, and stakeholder communications.

A premium broad spectrum distillate built around a balanced CBD and CBG profile with additional minor cannabinoids and crystal-resistant flow behaviour.

The ingredient is refined to retain meaningful CBD and CBG concentrations with selected minor cannabinoids. Its crystal-resistant behaviour is designed to preserve viscosity and handling performance during shelf life.

The commercial advantage is formulation freedom. A near-balanced CBD and CBG input allows product teams to build differentiated cannabinoid profiles while reducing crystallisation risk in formats where flowability matters.

Use these pages to move between adjacent products without losing the family context.

Send the Cilo Cybin team your target format, desired specification, estimated volume, destination market, and documentation requirements.

Pharmaceutical biotechnology for regulated cannabinoid API's, bulk products, finished formats, and partner supply programs.

For partnership, product, or company enquiries, contact Cilo Cybin for the latest approved information.